Not recruiting
Breast cancer
Not recruitingRegistered drugNo placebo
Study on the Safety and Antitumor Activity of ARV-471 and Ribociclib in Adults with ER+ Advanced or Metastatic Breast Cancer
Registered drugNo placebo
- Disease:Breast cancer
- Substances:Ribociclib(3S)-3-[6-[4-[[1-[4-[(1R,2S)-6-Hydroxy-2-Phenyl-1,2,3,4-Tetrahydronaphthalen-1-Yl]Phenyl]Piperidin-4-Yl]Methyl]Piperazin-1-Yl]-3-Oxo-1H-Isoindol-2-Yl]Piperidine-2,6-Dione
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Ribociclib
